Malaria drugs under watch: resistance study in kenya

NCT ID NCT07362498

Completed Knowledge-focused Sponsor: Strathmore University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study in western Kenya looked at how well different malaria drugs work and whether the parasites are becoming resistant. Researchers tested four artemisinin-based combination therapies across 28 health facilities over 28 months, involving 316 people with uncomplicated malaria. The goal was to see if using multiple first-line treatments is practical and acceptable, and to track resistance markers in the malaria parasite.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artemether + Lumefantrine and Dihydroartemisinin-piperaquine
What this could lead to: If successful, this could help health officials choose the best combination of malaria drugs to slow down resistance and keep treatments effective longer.
What could go wrong: This is an observational study, not a test of a new cure. The findings may not apply to other regions, and drug resistance patterns can change over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malaria Plasmodium falciparum malaria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MALARIA,FALCIPARUM

Contacts and locations

Locations

Homa Bay County Health Facilities

Homa Bay, Homa Bay County, 40300, Kenya
Migori County Teaching and Referral Hospital

Migori, Migori County Kenya, 40400, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.